Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
1.
Microbiol Mol Biol Rev ; 80(2): 451-93, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27122598

ABSTRACT

5-Deazaflavin cofactors enhance the metabolic flexibility of microorganisms by catalyzing a wide range of challenging enzymatic redox reactions. While structurally similar to riboflavin, 5-deazaflavins have distinctive and biologically useful electrochemical and photochemical properties as a result of the substitution of N-5 of the isoalloxazine ring for a carbon. 8-Hydroxy-5-deazaflavin (Fo) appears to be used for a single function: as a light-harvesting chromophore for DNA photolyases across the three domains of life. In contrast, its oligoglutamyl derivative F420 is a taxonomically restricted but functionally versatile cofactor that facilitates many low-potential two-electron redox reactions. It serves as an essential catabolic cofactor in methanogenic, sulfate-reducing, and likely methanotrophic archaea. It also transforms a wide range of exogenous substrates and endogenous metabolites in aerobic actinobacteria, for example mycobacteria and streptomycetes. In this review, we discuss the physiological roles of F420 in microorganisms and the biochemistry of the various oxidoreductases that mediate these roles. Particular focus is placed on the central roles of F420 in methanogenic archaea in processes such as substrate oxidation, C1 pathways, respiration, and oxygen detoxification. We also describe how two F420-dependent oxidoreductase superfamilies mediate many environmentally and medically important reactions in bacteria, including biosynthesis of tetracycline and pyrrolobenzodiazepine antibiotics by streptomycetes, activation of the prodrugs pretomanid and delamanid by Mycobacterium tuberculosis, and degradation of environmental contaminants such as picrate, aflatoxin, and malachite green. The biosynthesis pathways of Fo and F420 are also detailed. We conclude by considering opportunities to exploit deazaflavin-dependent processes in tuberculosis treatment, methane mitigation, bioremediation, and industrial biocatalysis.


Subject(s)
Flavins/physiology , Riboflavin/analogs & derivatives , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Archaea/metabolism , Euryarchaeota/metabolism , Humans , Metabolic Networks and Pathways , Mycobacterium/metabolism , Mycobacterium Infections/drug therapy , Oxidation-Reduction , Riboflavin/physiology
3.
In Vitro Cell Dev Biol Anim ; 50(8): 707-13, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24789726

ABSTRACT

Wolbachia is an obligate intracellular alphaproteobacterium that occurs in arthropod and nematode hosts. Wolbachia presumably provides a fitness benefit to its hosts, but the basis for its retention and spread in host populations remains unclear. Wolbachia genomes retain biosynthetic pathways for some vitamins, and the possibility that these vitamins benefit host cells provides a potential means of selecting for Wolbachia-infected cell lines. To explore whether riboflavin produced by Wolbachia is available to its host cell, we established that growth of uninfected C7-10 mosquito cells decreases in riboflavin-depleted culture medium. A well-studied inhibitor of riboflavin uptake, lumiflavin, further inhibits growth of uninfected C7-10 cells with an LC50 of approximately 12 µg/ml. Growth of C/wStr1 mosquito cells, infected with Wolbachia from the planthopper, Laodelphax striatellus, was enhanced in medium containing low levels of lumiflavin, but Wolbachia levels decreased. Lumiflavin-enhanced growth thus resembled the improved growth that accompanies treatment with antibiotics that deplete Wolbachia, rather than a metabolic advantage provided by the Wolbachia infection. We used the polymerase chain reaction to validate the decrease in Wolbachia abundance and evaluated our results in the context of a proteomic analysis in which we detected nearly 800 wStr proteins. Our data indicate that Wolbachia converts riboflavin to FMN and FAD for its own metabolic needs, and does not provide a source of riboflavin for its host cell.


Subject(s)
Aedes/microbiology , Riboflavin/physiology , Wolbachia , Aedes/chemistry , Aedes/drug effects , Animals , Cells, Cultured , Culture Media , Flavins/pharmacology , Proteomics , Riboflavin/analysis , Wolbachia/genetics , Wolbachia/growth & development
4.
Subcell Biochem ; 56: 229-45, 2012.
Article in English | MEDLINE | ID: mdl-22116702

ABSTRACT

Riboflavin (7,8-dimethyl-10-ribitylisoalloxazine; vitamin B2) is a water-soluble vitamin, cofactor derivatives of which (FAD, FMN) act as electron acceptors in the oxidative metabolism of carbohydrate, amino acids and fatty acids and which in the reduced state can donate electrons to complex II of the electron transport chain. This means that riboflavin is essential for energy generation in the aerobic cell, through oxidative phosphorylation. The classic effects of riboflavin deficiency on growth and development have generally been explained in terms of these functions. However, research also suggests that riboflavin may have specific functions associated with cell fate determination, which would have implications for growth and development. In particular, riboflavin depletion interferes with the normal progression of the cell cycle, probably through effects on the expression of regulatory genes, exerted at both the transcriptional and proteomic level.


Subject(s)
Cell Differentiation , Growth and Development , Riboflavin/physiology , Animals , Cell Cycle/drug effects , Cell Differentiation/drug effects , Enterocytes/drug effects , Enterocytes/physiology , Gastrointestinal Tract/drug effects , Gastrointestinal Tract/growth & development , Growth and Development/drug effects , Humans , Riboflavin/chemistry , Riboflavin/pharmacology , Riboflavin Deficiency/complications , Riboflavin Deficiency/metabolism
5.
ScientificWorldJournal ; 11: 1226-42, 2011 Jun 09.
Article in English | MEDLINE | ID: mdl-21666992

ABSTRACT

Since 2004, the anatomical distribution of vitamins in the monkey brain, studied using immunohistochemical techniques and new tools (specific antisera that discriminate different vitamins reasonably well), has been an ongoing research field. The visualization of immunoreactive structures containing vitamins (folic acid, riboflavin, thiamine, pyridoxal, and vitamin C) has recently been reported in the monkey brain (Macaca fascicularis), all these vitamins showing a restricted or very restricted distribution. Folic acid, thiamine, and riboflavin have only been observed in immunoreactive fibers, vitamin C has only been found in cell bodies (located in the primary somatosensory cortex), and pyridoxal has been found in both fibers and cell bodies. Perikarya containing pyridoxal have been observed in the paraventricular hypothalamic nucleus, the periventricular hypothalamic region, and in the supraoptic nucleus. The fibers containing vitamins are thick, smooth (without varicosities), and are of medium length or long, whereas immunoreactive cell bodies containing vitamins are round or triangular. At present, there are insufficient data to elucidate the roles played by vitamins in the brain, but the anatomical distribution of these compounds in the monkey brain provides a general idea (although imprecise and requiring much more study) about the possible functional implications of these molecules. In this sense, here the possible functional roles played by vitamins are discussed.


Subject(s)
Brain/metabolism , Macaca fascicularis/metabolism , Vitamins/physiology , Animals , Antibodies/analysis , Ascorbic Acid/immunology , Ascorbic Acid/metabolism , Ascorbic Acid/physiology , Folic Acid/immunology , Folic Acid/metabolism , Folic Acid/physiology , Pyridoxal/immunology , Pyridoxal/metabolism , Pyridoxal/physiology , Riboflavin/immunology , Riboflavin/metabolism , Riboflavin/physiology , Thiamine/immunology , Thiamine/metabolism , Thiamine/physiology , Vitamins/immunology , Vitamins/metabolism
6.
Curr Med Chem ; 17(32): 3842-54, 2010.
Article in English | MEDLINE | ID: mdl-20858216

ABSTRACT

Riboflavin, commonly known as vitamin B2, is the precursor of flavin cofactors. It is present in our typical diet, and inside the cells it is metabolized to FMN and FAD. As a result of their rather unique and flexible chemical properties these flavins are among the most important redox cofactors present in a large series of different enzymes. A problem in riboflavin metabolism or a low intake of this vitamin will have consequences on the level of FAD and FMN in the cell, resulting in disorders associated with riboflavin deficiency. In a few number of cases, riboflavin deficiency is associated with impaired oxidative folding, cell damage and impaired heme biosynthesis. More relevant are several studies referring reduced activity of enzymes such as dehydrogenases involved in oxidative reactions, respiratory complexes and enzymes from the fatty acid ß-oxidation pathway. The role of this vitamin in mitochondrial metabolism, and in particular in fatty acid oxidation, will be discussed in this review. The basic aspects concerning riboflavin and flavin metabolism and deficiency will be addressed, as well as an overview of the role of the different flavoenzymes and flavin chemistry in fatty acid ß-oxidation, merging clinical, cellular and biochemical perspectives. A number of recent studies shedding new light on the cellular processes and biological effects of riboflavin supplementation in metabolic disease will also be overviewed. Overall, a deeper understanding of these emerging roles of riboflavin intake is essential to design better therapies.


Subject(s)
Mitochondria/metabolism , Riboflavin/physiology , Carnitine Acyltransferases/metabolism , Humans , Multiple Acyl Coenzyme A Dehydrogenase Deficiency/metabolism , Oxidation-Reduction , Oxidoreductases Acting on CH-CH Group Donors/metabolism , Riboflavin/metabolism
7.
Food Nutr Bull ; 29(2 Suppl): S5-16; discussion S17-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18709878

ABSTRACT

This paper provides a general review on folate and vitamin B12 nutrition and metabolism and the metabolic interrelationship between these vitamins. The effects of some common polymorphisms in folate and vitamin B12 genes and the influence of vitamin B6 and riboflavin status on folate and vitamin B12 metabolism are also discussed.


Subject(s)
Folic Acid/metabolism , Polymorphism, Genetic , Riboflavin/physiology , Vitamin B 12/metabolism , Vitamin B 6/physiology , Biological Availability , Folic Acid/genetics , Folic Acid/pharmacokinetics , Humans , Intestinal Absorption , Riboflavin/metabolism , Vitamin B 12/genetics , Vitamin B 12/pharmacokinetics , Vitamin B 6/metabolism
8.
J Nutr ; 135(12 Suppl): 2960S-2966S, 2005 12.
Article in English | MEDLINE | ID: mdl-16317155

ABSTRACT

Epidemiological studies have linked low folate intake with an increased risk of epithelial cancers, including colorectal cancer and cervical cancer. Riboflavin has received much less attention, but there is increasing interest in the well-established role that flavins play in folate metabolism and the possible synergy of a protective effect between these 2 vitamins. Folate plays a key role in DNA synthesis, repair, and methylation, and this forms the basis of mechanistic explanations for a putative role for folate in cancer prevention. The role of folate in these processes may be modulated by genotype for the common C677T thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), homozygosity for which is associated with lower enzyme activity, lower plasma and red blood cell folate, and elevated plasma homocysteine. Riboflavin, as FAD, is a cofactor for MTHFR and there is evidently some interaction among riboflavin status, folate status, and genotype in determining plasma homocysteine, a functional marker of folate status. The MTHFR C677T polymorphism appears to interact with folate and riboflavin in modulating cancer risk in a manner that varies according to cancer site. Most evidence points to a protective effect of this polymorphism for risk of colorectal cancer, but the effect on cervical cancer risk is not clear. The effect of this polymorphism on cancer risk seems to be further modulated by other factors, including alcohol and, in the case of cervical cancer, infection with the human papilloma virus. An additional factor determining the effect of diet and genotype interactions on cancer risk may be the stage of cancer development.


Subject(s)
Colorectal Neoplasms/prevention & control , Folic Acid/therapeutic use , Riboflavin/therapeutic use , Uterine Cervical Neoplasms/prevention & control , Colorectal Neoplasms/genetics , Drug Interactions , Female , Folic Acid/physiology , Genotype , Humans , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Papillomavirus Infections/complications , Papillomavirus Infections/prevention & control , Riboflavin/physiology , Uterine Cervical Neoplasms/genetics , Uterine Cervical Dysplasia/etiology
9.
Community Pract ; 78(10): 366-8, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16245676

ABSTRACT

Vitamins and minerals are organic food substances found only in plants and animals and are essential to the normal functioning of the body. Although only required in small amounts, as previously discussed in the past decade there has been an increased use of vitamin, mineral, herbal and nutritional supplements in the general population. While deficiencies in such nutrients can be harmful to health, conflicting claims have been made about the health benefits of such supplementation. In the second of an occasional series on vitamins, minerals, and supplements, JUNE THOMPSON gives an overview of the role that water-soluble vitamins play in the health of the individual, including their functions, and the potential impact of any deficiency of these.


Subject(s)
Dietary Supplements , Vitamin B Complex/administration & dosage , Vitamin B Complex/physiology , Food , Humans , Niacin/administration & dosage , Niacin/physiology , Nutrition Policy , Pantothenic Acid/administration & dosage , Pantothenic Acid/physiology , Riboflavin/administration & dosage , Riboflavin/physiology , Thiamine/administration & dosage , Thiamine/physiology , Vitamin B Deficiency/diagnosis , Vitamin B Deficiency/therapy
10.
J Nutr Biochem ; 16(10): 617-24, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16081269

ABSTRACT

Flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) are essential coenzymes in redox reactions. For example, FAD is a coenzyme for both glutathione reductase and enzymes that mediate the oxidative folding of secretory proteins. Here we investigated short-term effects of moderately riboflavin-deficient culture medium on flavin-related responses in HepG2 hepatocarcinoma cells. Cells were cultured in riboflavin-deficient (3.1 nmol/l) medium for up to 6 days; controls were cultured in riboflavin-sufficient (532 nmol/l) medium. The activity of glutathione reductase decreased by 98% within 4 days of riboflavin-deficient culture. Transport rates of riboflavin increased in response to riboflavin depletion, whereas expression of enzymes mediating flavocoenzyme synthesis (flavokinase and FAD synthetase) decreased in response to depletion. The oxidative folding and synthesis of plasminogen and apolipoprotein B-100 was impaired within 4 days of culture in riboflavin-deficient medium; this is consistent with impaired processing of secretory proteins in riboflavin-deficient cells. Riboflavin depletion was associated with increased DNA-binding activities of transcription factors with affinity for endoplasmic reticulum stress elements and nuclear factor kappaB (NF-kappaB) consensus elements, suggesting cell stress. Moreover, the abundance of the stress-induced protein GADD153 was greater in riboflavin-deficient cells compared with controls. Riboflavin deficiency was associated with decreased rates of cell proliferation caused by arrest in G1 phase of the cell cycle. These studies are consistent with the hypothesis that HepG2 cells have a great demand for riboflavin and that cell stress develops rapidly if riboflavin supply is marginally low.


Subject(s)
Culture Media/chemistry , Riboflavin Deficiency , Riboflavin/physiology , Biological Transport , CCAAT-Enhancer-Binding Proteins/analysis , Carcinoma, Hepatocellular , Cell Division , Cell Line, Tumor , DNA/metabolism , Endoplasmic Reticulum/metabolism , G1 Phase , Glutathione Reductase/metabolism , Humans , Liver Neoplasms , NF-kappa B/metabolism , Nucleotidyltransferases/metabolism , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Protein Biosynthesis , Protein Folding , Riboflavin/administration & dosage , Time Factors , Transcription Factor CHOP , Transcription Factors/analysis , Transcription Factors/metabolism
11.
Curr Sports Med Rep ; 4(4): 207-13, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16004830

ABSTRACT

For more than 50 years, the Food and Nutrition Board of the National Academy of Sciences has been reviewing nutrition research and defining nutrient requirements for healthy people, referred to as the recommended dietary allowances (RDA). As new nutrition research is published, the importance of vitamins as vital nutrients is underscored, and new physiologic roles and applications to human health are examined and considered with regard to updating the RDA. Each year a substantial amount of research is published on vitamins. This article examines and summarizes noteworthy research published on individual water-soluble vitamins (excluding vitamin C) in the past 12 months, provides relevant background information on these vitamins, and offers critical reviews as appropriate.


Subject(s)
Folic Acid/administration & dosage , Folic Acid/physiology , Vitamin B Complex/administration & dosage , Vitamin B Complex/physiology , Dietary Supplements , Female , Folic Acid/chemistry , Folic Acid Deficiency/complications , Folic Acid Deficiency/prevention & control , Homocysteine/drug effects , Homocysteine/metabolism , Humans , Male , Neural Tube Defects/etiology , Neural Tube Defects/prevention & control , Niacinamide/deficiency , Niacinamide/physiology , Niacinamide/therapeutic use , Nutritional Requirements , Pregnancy , Riboflavin/physiology , Riboflavin/therapeutic use , Riboflavin Deficiency/prevention & control , Solubility , Thiamine/physiology , Thiamine/therapeutic use , Thiamine Deficiency/prevention & control , Vitamin B 12/physiology , Vitamin B 12/therapeutic use , Vitamin B 12 Deficiency/prevention & control , Vitamin B 6/physiology , Vitamin B 6/therapeutic use , Vitamin B 6 Deficiency/prevention & control , Vitamin B Complex/chemistry , Vitamin B Deficiency/prevention & control
12.
Am J Clin Nutr ; 80(4): 1050-7, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15447919

ABSTRACT

BACKGROUND: The 5,10-methylenetetrahydrofolate reductase gene (MTHFR) 677C-->T polymorphism modifies the risk of coronary artery disease and colon cancer and is related to plasma concentrations of total homocysteine (tHcy). Riboflavin status modifies the metabolic effect of the polymorphism, and thyroid hormones increase the synthesis of flavin cofactors. OBJECTIVE: The aim of the study was to investigate the phenotypic expression of the MTHFR 677C-->T polymorphism in terms of plasma tHcy concentrations in patients with thyroid dysfunction. DESIGN: The study population consisted of 182 patients with hyperthyroidism. We studied plasma tHcy in relation to MTHFR genotype, riboflavin, and folate before and during 6 mo of treatment with antithyroid drugs. RESULTS: Before treatment, tHcy was higher in patients with the mutant enzyme than in those with the wild-type enzyme. A genotype effect was observed only at low riboflavin or folate concentrations (P T polymorphism, possibly by modifying the availability of flavin cofactors.


Subject(s)
Antithyroid Agents/therapeutic use , Homocysteine/blood , Hyperthyroidism/blood , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Polymorphism, Genetic , Riboflavin/blood , Adult , Female , Folic Acid/blood , Gene Expression Regulation , Genotype , Humans , Hyperthyroidism/drug therapy , Male , Middle Aged , Mutation , Phenotype , Regression Analysis , Riboflavin/physiology
14.
Can J Appl Physiol ; 29(6): 773-80, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15630149

ABSTRACT

Homocysteine is a sulfur-containing amino acid that arises during methionine metabolism. Although its concentration in plasma is only about 10 micromolar, even moderate hyperhomocysteinemia is associated with increased incidence of cardiovascular disease and Alzheimer's disease. Elevations in plasma homocysteine are commonly found as a result of vitamin deficiencies, polymorphisms of enzymes of methionine metabolism, and renal disease. Pyridoxal, folic acid, riboflavin, and Vitamin B(12) are all required for methionine metabolism, and deficiency of each of these vitamins result in elevated plasma homocysteine. A polymorphism of methylenetetrahydrofolate reductase (C677T), which is quite common in most populations with a homozygosity rate of 10-15 %, is associated with moderate hyperhomocysteinemia, especially in the context of marginal folate intake. Plasma homocysteine is inversely related to plasma creatinine in patients with renal disease. This is due to an impairment in homocysteine removal in renal disease. The role of these factors, and of modifiable lifestyle factors, in affecting methionone metabolism and in determining plasma homocysteine levels is discussed.


Subject(s)
Cardiovascular Diseases/etiology , Homocysteine/blood , Life Style , Nutritional Physiological Phenomena , Avitaminosis/blood , Cardiovascular Diseases/blood , Cardiovascular Diseases/genetics , Creatinine/blood , Folic Acid/physiology , Homocysteine/physiology , Humans , Incidence , Kidney Diseases/blood , Methionine/metabolism , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Methylenetetrahydrofolate Reductase (NADPH2)/physiology , Polymorphism, Genetic , Pyridoxal/physiology , Riboflavin/physiology , Vitamin B 12/physiology
15.
Adv Drug Deliv Rev ; 55(11): 1467-83, 2003 Nov 14.
Article in English | MEDLINE | ID: mdl-14597141

ABSTRACT

The role of riboflavin in cell maintenance and growth, and the mechanism by which it is absorbed into various human tissues and cell lines has been extensively studied over the past decade. Evidence suggests two absorption mechanisms, a saturable-active component that dominates at near physiological vitamin concentrations and a passive component that is revealed at oversupplemented riboflavin conditions. Various transport modulator studies consistently suggest a highly riboflavin specific, temperature-dependent active transport mechanism that is regulated by the Ca2+/calmodulin pathway. The PKA and PKG pathways have also been implicated in absorption regulation. The long-standing model that riboflavin absorption involves a carrier-mediated transporter has recently been challenged through studies suggesting a receptor-mediated endocytic component. The presence of a soluble, human riboflavin binding protein in the transport stratagem has been shown to play an important role in fetal development. The relationship of this binding protein with the riboflavin specific membrane bound protein, though currently not well defined, may involve a protein-protein interaction that plays a primary role in this proposed receptor-mediated component.


Subject(s)
Riboflavin/metabolism , Animals , Biological Transport , Carrier Proteins/metabolism , Cell Division , Folic Acid/metabolism , Humans , Receptors, Cell Surface/metabolism , Riboflavin/physiology , Species Specificity , Temperature
16.
J Mol Biol ; 332(5): 1047-57, 2003 Oct 03.
Article in English | MEDLINE | ID: mdl-14499608

ABSTRACT

The fourth reaction step of CO(2)-reduction to methane in methanogenic archaea is catalyzed by coenzyme F(420)-dependent methylenetetrahydromethanopterin dehydrogenase (Mtd). We have structurally characterized this enzyme in the selenomethionine-labelled form from the hyperthermophilic methanogenic archaeon Methanopyrus kandleri at 1.54A resolution using the single wavelength anomalous dispersion method for phase determination. Mtd was found to be a homohexameric protein complex that is organized as a trimer of dimers. The fold of the individual subunits is composed of two domains: a larger alpha,beta domain and a smaller helix bundle domain with a short C-terminal beta-sheet segment. In the homohexamer the alpha,beta domains are positioned at the outside of the enzyme, whereas, the helix bundle domains assemble towards the inside to form an unusual quarternary structure with a 12-helix bundle around a 3-fold axis. No structural similarities are detectable to other enzymes with F(420) and/or substituted tetrahydropterins as substrates. The substrate binding sites of F(420) and methylenetetrahydromethanopterin are most likely embedded into a crevice between the domains of one subunit, their isoalloxazine and tetrahydropterin rings being placed inside a pocket formed by this crevice and a loop segment of the adjacent monomer of the dimer. Mtd revealed the highest stability at low salt concentrations of all structurally characterized enzymes from M.kandleri. This finding might be due to the compact quaternary structure that buries 36% of the monomer surface and to the large number of ion pairs.


Subject(s)
Euryarchaeota/enzymology , Oxidoreductases Acting on CH-NH Group Donors/metabolism , Riboflavin/analogs & derivatives , Riboflavin/metabolism , Riboflavin/physiology , Amino Acid Sequence , Catalysis , Crystallography, X-Ray , Dimerization , Electrons , Models, Chemical , Models, Molecular , Molecular Sequence Data , Protein Binding , Protein Folding , Protein Structure, Quaternary , Protein Structure, Secondary , Protein Structure, Tertiary , Salts/pharmacology , Software
17.
J Nutr ; 133(3): 668-72, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12612135

ABSTRACT

Secretory proteins such as interleukin (IL)-2 undergo oxidative folding (disulfide formation) in the endoplasmic reticulum (ER) before secretion. Studies in yeast have suggested that oxidative folding depends on the flavoprotein Ero1p; unfolded proteins accumulate in the ER, triggering cellular stress response. Here, human lymphoid cells (Jurkat cells) were used to model effects of cellular flavin supply on secretion of IL-2 (containing one disulfide bond) and cellular stress response. Cells were cultured in media containing 0.85, 3.1, 12.6 or 300.6 nmol/L riboflavin for 5 wk, representing severely deficient, moderately deficient, physiologic and pharmacologic plasma concentrations in humans, respectively. Transport rates of riboflavin were increased in severely and moderately deficient cells compared with cells cultured in physiologic medium; this increase was not sufficient to prevent intracellular depletion of riboflavin, as judged by glutathione reductase activity and intracellular concentrations of glutathione. Intracellular accumulation of IL-2 was greater in severely deficient cells than in other groups. Nevertheless, severely deficient cells secreted normal amounts of IL-2 into the extracellular space, mediated by increased transcriptional activity of the IL-2 gene. Riboflavin-deficient cells responded to intracellular accumulation of IL-2 with increased expression of genes encoding ubiquitin-activating enzyme E1 and X box-binding protein, consistent with cellular stress. These findings are consistent with the hypothesis that flavin deficiency may cause cellular stress by accumulation of unfolded proteins in human cells.


Subject(s)
Flavins/deficiency , Interleukin-2/chemistry , Interleukin-2/metabolism , Protein Folding , Biological Transport , Cell Division , Endoplasmic Reticulum/metabolism , Gene Expression , Humans , Interleukin-2/genetics , Iodine Radioisotopes , Jurkat Cells , Membrane Glycoproteins/physiology , Molecular Sequence Data , Oxidation-Reduction , Oxidoreductases , RNA, Messenger/analysis , Riboflavin/administration & dosage , Riboflavin/analysis , Riboflavin/physiology
18.
Am J Clin Nutr ; 76(2): 436-41, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12145019

ABSTRACT

BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR; EC 1.7.99.5) supplies the folate needed for the metabolism of homocysteine. A reduction in MTHFR activity, as occurs in the homozygous state for the 677C-->T (so-called thermolabile) enzyme variant (TT genotype), is associated with an increase in plasma total homocysteine (tHcy). OBJECTIVE: In vitro studies suggest that the reduced activity of thermolabile MTHFR is due to the inappropriate loss of its riboflavin cofactor. We investigated the hypothesis that MTHFR activity in the TT genotype group is particularly sensitive to riboflavin status. DESIGN: We studied tHcy and relevant B-vitamin status by MTHFR genotype in a cross-sectional study of 286 healthy subjects aged 19-63 y (median: 27 y). The effect of riboflavin status was examined by dividing the sample into tertiles of erythrocyte glutathionine reductase activation coefficient, a functional index of riboflavin status. RESULTS: Lower red blood cell folate (P = 0.0001) and higher tHcy (P = 0.0082) concentrations were found in the TT group than in the heterozygous (CT) or wild-type (CC) groups. However, these expected relations in the total sample were driven by the TT group with the lowest riboflavin status, whose mean tHcy concentration (18.09 micromol/L) was almost twice that of the CC or CT group. By contrast, adequate riboflavin status rendered the TT group neutral with respect to tHcy metabolism. CONCLUSIONS: The high tHcy concentration typically associated with homozygosity for the 677C-->T variant of MTHFR occurs only with poor riboflavin status. This may have important implications for governments considering new fortification policies aimed at the prevention of diseases for which this genotype is associated with increased risk.


Subject(s)
Homocysteine/blood , Oxidoreductases Acting on CH-NH Group Donors/genetics , Riboflavin/blood , Adult , Analysis of Variance , Female , Folic Acid/blood , Genotype , Humans , Male , Methylenetetrahydrofolate Reductase (NADPH2) , Middle Aged , Nutritional Requirements , Nutritional Status , Oxidoreductases Acting on CH-NH Group Donors/metabolism , Polymerase Chain Reaction , Riboflavin/physiology
19.
Mol Plant Microbe Interact ; 15(5): 456-62, 2002 May.
Article in English | MEDLINE | ID: mdl-12036276

ABSTRACT

Genes contributing to riboflavin production in Sinorhizobium meliloti were identified, and bacterial strains that overproduce this vitamin were constructed to characterize how additional riboflavin affects interactions between alfalfa (Medicago sativa) and S. meliloti. Riboflavin-synthesis genes in S. meliloti were found in three separate linkage groups and designated as ribBA, ribDribC, and ribH for their similarities to Escherichia coli genes. The ribBA and ribC loci complemented corresponding E. coli rib mutants. S. meliloti cells containing extra copies of ribBA released 10 to 20% more riboflavin than a control strain but grew at similar rates in a defined medium lacking riboflavin. Cells carrying extra copies of ribBA colonized roots to densities that were 55% higher than that of a control strain. No effect of extra rib genes was detected on alfalfa grown in the absence or presence of combined N. These results support the importance of extracellular riboflavin for alfalfa root colonization by S. meliloti and are consistent with the hypothesis that this molecule benefits bacteria indirectly through an effect on the plant.


Subject(s)
GTP Cyclohydrolase/genetics , Intramolecular Transferases/genetics , Medicago sativa/physiology , Riboflavin Synthase/genetics , Riboflavin/biosynthesis , Sinorhizobium/physiology , Symbiosis/physiology , Amino Acid Sequence , Bacterial Proteins/genetics , Bacterial Proteins/physiology , GTP Cyclohydrolase/physiology , Intramolecular Transferases/physiology , Medicago sativa/microbiology , Molecular Sequence Data , Plant Roots/microbiology , Plant Roots/physiology , Riboflavin/physiology , Riboflavin Synthase/physiology , Sequence Homology, Amino Acid , Sinorhizobium/genetics , Symbiosis/genetics
20.
Environ Microbiol ; 3(9): 545-50, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11683864

ABSTRACT

Riboflavin (vitamin B2), essential in tiny amounts as a precursor for oxidoreductase coenzymes, is a yellow pigment. Although it causes cytotoxicity via photoinduced damage of macromolecules, several microorganisms are striking overproducers. A question, unanswered for decades, is whether riboflavin overproducers can benefit from this property. Here, we report an ultraviolet (UV) protective effect of riboflavin. The spores of Ashbya gossypii, a riboflavin-overproducing fungus, are more sensitive to UV than those of Aspergillus nidulans. The addition of riboflavin to suspensions improves the UV resistance of both spore types. Interestingly, we show that regulation of sporulation and riboflavin overproduction in A. gossypii are linked. In batch culture, both were elevated when growth ceased. At constant growth rates, obtained in a chemostat culture, neither was elevated. Supplementation of cultures by cAMP, a known stress signal, negatively affected sporulation as well as riboflavin overproduction, establishing a second, independent argument for the linkage.


Subject(s)
Riboflavin/physiology , Saccharomycetales/physiology , Hyalin , Kinetics , Radiation Tolerance , Riboflavin/biosynthesis , Riboflavin/genetics , Saccharomycetales/enzymology , Saccharomycetales/radiation effects , Spores, Fungal/radiation effects , Ultraviolet Rays
SELECTION OF CITATIONS
SEARCH DETAIL
...